Matches in Wikidata for { <http://www.wikidata.org/entity/Q66075597> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q66075597 description "clinical trial" @default.
- Q66075597 description "ensayu clínicu" @default.
- Q66075597 description "klinisch onderzoek" @default.
- Q66075597 description "клінічне випробування" @default.
- Q66075597 name "Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration" @default.
- Q66075597 name "Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration" @default.
- Q66075597 type Item @default.
- Q66075597 label "Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration" @default.
- Q66075597 label "Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration" @default.
- Q66075597 prefLabel "Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration" @default.
- Q66075597 prefLabel "Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration" @default.
- Q66075597 P1050 Q66075597-89BF1950-6F4A-4833-AD4C-A3781DC8611B @default.
- Q66075597 P1132 Q66075597-91908296-43C4-4F11-B188-9F8992AE4AB2 @default.
- Q66075597 P1476 Q66075597-E08082D9-24A0-4623-B0C9-60B9A7D0252E @default.
- Q66075597 P17 Q66075597-A5C0E60D-0009-4DF7-A390-906119F5CC89 @default.
- Q66075597 P1813 Q66075597-7D56F393-0731-4C62-8103-3E3C2E6B35C0 @default.
- Q66075597 P2899 Q66075597-FBA8BF0F-4534-476A-82C8-670355C7C460 @default.
- Q66075597 P3098 Q66075597-79424841-BD53-4DCD-8C18-5942E2EBDADA @default.
- Q66075597 P31 Q66075597-AF2BBF67-22C5-4498-ADE6-675B0BB79D05 @default.
- Q66075597 P4844 Q66075597-3F6F8B2E-D614-4731-B342-06140C590BC1 @default.
- Q66075597 P4844 Q66075597-C29E4DBD-178D-47E3-BB02-38F44EF0EA4B @default.
- Q66075597 P580 Q66075597-2B74370A-A0D0-4A4D-B858-531A39E53391 @default.
- Q66075597 P582 Q66075597-A8669710-BD54-4DF5-9355-32497FA80D6B @default.
- Q66075597 P6099 Q66075597-7E045DB8-AC20-47D3-A76A-83BC6A05263C @default.
- Q66075597 P6099 Q66075597-A240472C-4031-422E-AC77-04718729E858 @default.
- Q66075597 P6153 Q66075597-639E5D73-22F6-4D8B-8038-C680136B760C @default.
- Q66075597 P6153 Q66075597-ECFE1EE7-34DA-41BA-90A7-E8EA7C96B751 @default.
- Q66075597 P8363 Q66075597-82B8FADE-D359-4514-99EF-0AA0557BA439 @default.
- Q66075597 P859 Q66075597-166CEF54-C8E3-4B92-85FA-DF068EDFBD07 @default.
- Q66075597 P1050 Q27429789 @default.
- Q66075597 P1132 "+50" @default.
- Q66075597 P1476 "A Randomized Controlled Trial Comparing the Effect of Topical Dorzolamide-Timolol Versus Placebo Combined With Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Injections in Patients With Neovascular Age-Related Macular Degeneration Who Are Incomplete Anti-VEGF Responders" @default.
- Q66075597 P17 Q30 @default.
- Q66075597 P1813 "DAWN" @default.
- Q66075597 P2899 "+45" @default.
- Q66075597 P3098 "NCT03034772" @default.
- Q66075597 P31 Q30612 @default.
- Q66075597 P4844 Q1703024 @default.
- Q66075597 P4844 Q413299 @default.
- Q66075597 P580 "2017-02-08T00:00:00Z" @default.
- Q66075597 P582 "2018-11-28T00:00:00Z" @default.
- Q66075597 P6099 Q42824440 @default.
- Q66075597 P6099 Q42824827 @default.
- Q66075597 P6153 Q30270222 @default.
- Q66075597 P6153 Q7128506 @default.
- Q66075597 P8363 Q78089383 @default.
- Q66075597 P859 Q8022473 @default.